The global market for media, sera and reagents used in biotechnology was
valued at $2.3 billion in 2009, $2.5 billion in 2010 and is estimated to have
reached nearly $2.8 billion at the end of 2011. The market is expected to
reach $4.2 billion by 2016, a compound annual growth rate (CAGR) of 8.8%.
The reagents market reached $1 billion in 2010 and nearly $1.2 billion in
2011. It is expected to grow to $2 billion by 2016, a CAGR of 11.3%.
The media segment reached $820.7 million in 2010 and $897.4 million in 2011.
It is expected to grow to $1.4 billion by 2016, a CAGR of 9.4%.
REPORT SCOPE
INTRODUCTION
STUDY OBJECTIVES
BCC's goal in conducting this study is to provide an overview of the current
and future characteristics of the global market for media, sera and the
reagents used in biotechnology. The key objective is to present a
comprehensive analysis of the current market and its future direction in the
media, sera and biotechnology reagents markets as an important tool for the
cell culture industry.
This report explores present and future strategies within the media and sera
market, including reagents used in biotechnology. The improvisation of the
market, the setbacks and the needs of the market are discussed in this report.
The types of cell cultures and the products from cell culture technology are
also presented in this report. The advantages and disadvantages for the use
of various types of media are also covered in this report.
A detailed analysis of the cell culture industry structure has been conducted.
This includes the biotechnology reagents, media and the sera used. Revenues
are broken down by global region. Sales figures are estimated for the
five-year period from 2011 through 2016.
Applications for the cell culture industry - media, sera and reagents used in
biotechnology - are also discussed in the report, with an emphasis on the
usage in the research, production and contract segments. The report also
covers significant patents in each segment.
REASONS FOR DOING THIS STUDY
Demand for cell culture products, namely media, sera and reagents, is
increasing, with the increasing demand for biopharmaceuticals. Cell culture,
a crucial component of the life sciences industry, has witnessed major
development during the past three decades. R&D spending, along with
increasing competition, patent expiries, new technologies and an international
marketplace are moving the cell culture process in a new direction. As cell
culture technologies evolved, a number of disciplines such as cell biology,
genetic engineering, protein chemistry, genomics and chemical engineering have
been successfully incorporated into the cell culture field.
Acquisition strategies and collaborations by companies are also covered in
this report. This study also discusses the strength and weaknesses of the
different types of media used in light of the new technologies, growing
competition and changing customer needs.
INTENDED AUDIENCE
This study contributes to the areas of market growth in the cell culture
industry from the point of view of manufacturers and users. Biotechnological
companies, physicians, the pharmaceutical and biopharmaceutical industries,
hospitals and research institutes will find this study to be of interest.
SCOPE OF THE STUDY
The scope of this study encompasses the biotechnology, pharmaceutical and
medical markets. BCC analyzes each market and its applications by its need
for development of new medications through cell culture techniques, the
regulatory environment, technology involved, market projections and market
share. Technological issues include the latest trends and developments.
METHODOLOGY
BCC conducted a comprehensive literature search, which included technical
newsletters and journals, and many other sources. Data was collected through
interviews and correspondence with various analytical, chemical,
pharmaceutical and biotechnical experts. Projections were based on estimates
such as the current number of end users, potential end users, mergers and
acquisitions, and market trends.
INFORMATION SOURCES
Many companies within the industry were surveyed to obtain data for this
study. Included were manufacturers and end users of biopharmaceuticals, and
pharmaceutical companies through their production, research and contract
manufacturing/research lines. Data were gathered from various industry
sources. BCC spoke with officials and physicians within the industry,
consulted newsletters, company literature, product literature and a host of
technical articles, journals, indexes and abstracts. Exhaustive
investigations of databases by key terminology were completed. In addition,
data were compiled from current financial, trade and government sources.
ABOUT THE AUTHOR
The study has been carried out by a team of professionals in the biotechnology
industry. The project manager for this project is Shalini S. Dewan, who holds
a Master's degree in Pharmaceutical Chemistry and has more than 14 years of
industry experience. Among the research topics she has covered are studies on
compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl
acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India
for her work and has worked with top companies in India and in the U.S. Some
of her other reports with BCC are Reagents for Chromatography; Spectroscopy,
an Enduring Market; Advanced Drug Delivery Systems: Technologies and Global
Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and
Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media,
Sera and Reagent Market in Biotechnology; Contract Pharmaceutical
Manufacturing, Research and Packaging: Global Markets; Chiral Technology:
Global Markets; Autacoids and Related Drugs: Technologies and Global Markets;
Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The
Global Market; Hormone Replacement Therapies and Other Hormone Therapies:
Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and
Cancer Therapies: Technologies and Global Markets.
The lead consultant for this project was Dr. Kapil A. Setia, who holds a
doctoral degree in the life sciences. She has a number of research
publications to her credit.
Table of Contents
Table of Contents
Chapter- 1: INTRODUCTION - Complimentary
STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
INTENDED AUDIENCE
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ABOUT THE AUTHOR
RELATED BCC RESEARCH REPORTS
BCC ONLINE SERVICES
DISCLAIMER
Chapter- 2: EXECUTIVE SUMMARY
Table Summary : GLOBAL REVENUES FROM MEDIA, SERA AND REAGENTS USED IN THE
BIOTECHNOLOGY MARKET, THROUGH 2016
Figure Summary : GLOBAL REVENUES FROM MEDIA, SERA AND REAGENTS USED IN THE
BIOTECHNOLOGY MARKET, 2009-2016
Chapter- 3: OVERVIEW
DEFINITIONS
HISTORY
TYPES OF CELL CULTURES
MORPHOLOGY OF CELLS IN CULTURE
BASIC SYSTEMS FOR CELL CULTURE
CELL LINE, CELL STRAIN AND TRANSFORMED CELL LINES
FACTORS AFFECTING CELL CULTURE
APPLICATIONS OF CELL CULTURE
PROBLEMS DURING CELL CULTURE
BASIC REQUIREMENTS OF CELL CULTURE
REGULATORY ASPECTS
APPROVALS OF BIOLOGICAL LICENSE APPLICATIONS
ADMINISTRATIVE ACTIONS: BIOLOGICS
LEADING MANUFACTURERS OF MEDIA
NEW DEVELOPMENTS
NEW DEVELOPMENTS IN APPLICATIONS
Table 24 : NEW DEVELOPMENTS IN APPLICATION OF CELL CULTURE
Chapter- 4: GLOBAL MARKETS
MEDIA
SERA
REAGENTS
Chapter- 5: U.S. MARKET
MEDIA
SERA
REAGENTS
U.S. MARKET LEADERS
Chapter- 6: EUROPEAN MARKET
MEDIA
SERA
REAGENTS
EUROPEAN MARKET LEADERS
Chapter- 7: ASIAN MARKET
MEDIA
SERA
REAGENTS
ASIAN MARKET LEADERS
Chapter- 8: EMERGING MARKETS/REST OF THE WORLD MARKET
MEDIA
SERA
REAGENTS
MARKET LEADERS IN THE EMERGING MARKETS
Chapter- 9: END USERS
MARKET SHARE OF APPLICATIONS
RESEARCH SEGMENT
PRODUCTION SEGMENT
CONTRACT SEGMENT
OTHERS SEGMENT
Chapter- 10: PATENT ANALYSIS
PATENTS BY YEAR
PATENTS BY TYPE
PATENTS BY COMPANY
PATENTS BY COUNTRY
PATENTS BY ASSIGNEE
Table 132 : U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS USED IN
BIOTECHNOLOGY BY TYPE OF END USER, 2007 TO OCT. 2011
Chapter- 11: THE CURRENT SITUATION
REGIONAL MARKETS
TRENDS AND ISSUES IN THE CELL CULTURE MARKET
Chapter- 12: COMPANY PROFILES
ADVANCED BIOTECHNOLOGIES INC.
AFFYMETRIX
AMRESCO LLC
ATHENA ENVIRONMENTAL SCIENCES INC.
ATLANTA BIOLOGICALS INC.
BD BIOSCIENCES
BIORECLAMATION INC.
BOVOGEN BIOLOGICALS PTY. LTD.
CELL APPLICATIONS INC.
CELL CULTURE TECHNOLOGIES GMBH
CLONTECH LABORATORIES INC.
EQUITECH-BIO INC.
GEMINI BIO-PRODUCTS
GENEX INDIA BIOSCIENCES PVT. LTD.
HIMEDIA LABORATORIES
INVITROGEN CORP.
IRVINE SCIENTIFIC
J R SCIENTIFIC INC.
LONZA
MEDIATECH INC.
MEDOX BIOTECH INDIA PVT. LTD.
MILLIPORE CORP.
MP BIOMEDICALS
PAA LABORATORIES
PEPROTECH INC.
PROMOCELL GMBH
QUALITY BIOLOGICAL INC.
R&D SYSTEMS
ROCHE APPLIED SCIENCES
SERA LABORATORIES INTERNATIONAL LTD.
SERACARE LIFE SCIENCES INC.
SIGMA-ALDRICH
STEMCELL TECHNOLOGIES
STEMCELLS INC.
THERMO FISHER SCIENTIFIC INC.
TICO EUROPE
VALLEY BIOMEDICAL PRODUCTS AND SERVICES INC.
Chapter- 13: APPENDIX: ABBREVIATIONS
List of Tables
Summary Table : GLOBAL REVENUES FROM MEDIA, SERA AND REAGENTS USED IN THE
BIOTECHNOLOGY MARKET, THROUGH 2016
Table 1 : HISTORICAL EVENTS IN CELL CULTURE DEVELOPMENT
Table 2 : ADVANTAGES AND DISADVANTAGES OF PRIMARY CELL CULTURE
Table 3 : ADVANTAGES AND DISADVANTAGES OF CONTINUOUS CELL CULTURE
Table 4 : ADHERENT CULTURE VS. SUSPENSION CULTURE
Table 5 : CULTURE MEDIA USED FOR THE PRODUCTION OF VACCINES
Table 6 : POTENTIAL SOURCES OF CELL CULTURE ADDITIVES
Table 7 : RECOMBINANT THROMBOLYTIC AGENTS
Table 8 : RECOMBINANT COAGULATION FACTOR
Table 9 : THE ROLES OF DIFFERENT INORGANIC NUTRIENTS
Table 10 : COMMONLY USED ANTIBIOTICS IN CELL CULTURES
Table 11 : ADVANTAGES AND DISADVANTAGES OF SERUM-CONTAINING MEDIA
Table 12 : ADVANTAGES AND DISADVANTAGES OF SERUM-FREE MEDIA
Table 13 : NORMAL RANGE OF CONCENTRATION OF SERUM CONSTITUENTS
Table 14 : APPROVALS OF BIOLOGICAL LICENSE APPLICATIONS, 2010 TO AUG. 2011
Table 15 : ADMINISTRATIVE ACTIONS: BIOLOGICS, 2007 TO AUG. 2011
Table 16 : PRODUCT RECALLS, 2007 TO AUG. 2011
Table 17 : LEADING MANUFACTURERS OF MEDIA
Table 18 : LEADING MANUFACTURERS OF SERA
Table 19 : LEADING MANUFACTURERS OF BIOLOGIC RESPONSE MODIFIERS
Table 20 : LEADING MANUFACTURERS OF CELL DISSOCIATION REAGENTS
Table 21 : LEADING MANUFACTURERS OF ANTIBIOTICS AND ANTIMYCOTICS USED IN
CELL CULTURE
Table 22 : LEADING MANUFACTURERS OF OTHER REAGENTS
Table 23 : NEW DEVELOPMENTS IN THE CELL CULTURE INDUSTRY SINCE 2008
Table 24 : NEW DEVELOPMENTS IN APPLICATION OF CELL CULTURE
Table 25 : GLOBAL MARKET FOR CELL CULTURE PRODUCTS, THROUGH 2016
Table 26 : GLOBAL MARKET FOR MEDIA USED IN BIOTECHNOLOGY BY REGION,
THROUGH 2016
Table 27 : GLOBAL BIOTECHNOLOGY MEDIA MARKET SHARES BY REGION, 2010
Table 28 : GLOBAL MARKET FOR SERUM-FREE MEDIA BY REGION, THROUGH 2016
Table 29 : GLOBAL MARKET FOR SERUM-REQUIRING MEDIA BY REGION, THROUGH 2016
Table 30 : GLOBAL MARKET FOR POWDERED MEDIA, THROUGH 2016
Table 31 : GLOBAL MARKET FOR LIQUID MEDIA BY REGION, THROUGH 2016
Table 32 : GLOBAL MARKET FOR CLASSICAL MEDIA BY REGION, THROUGH 2016
Table 33 : GLOBAL MARKET FOR SPECIALTY MEDIA BY REGION, THROUGH 2016
Table 34 : GLOBAL MARKET FOR SERA BY REGION, THROUGH 2016
Table 35 : GLOBAL SERA MARKET SHARES BY REGION, 2010
Table 36 : GLOBAL MARKET FOR BOVINE SERA BY REGION, THROUGH 2016
Table 37 : GLOBAL MARKET FOR OTHER SERA BY REGION, THROUGH 2016
Table 38 : GLOBAL MARKET FOR CELL CULTURE REAGENTS BY REGION, THROUGH 2016
Table 39 : GLOBAL CELL CULTURE REAGENT MARKET SHARES BY REGION, 2010
Table 40 : GLOBAL MARKET FOR BIOLOGICAL RESPONSE MODIFIERS BY REGION,
THROUGH 2016
Table 41 : GLOBAL MARKET FOR GROWTH FACTORS BY REGION, THROUGH 2016
Table 42 : GLOBAL MARKET FOR CYTOKINES BY REGION, THROUGH 2016
Table 43 : GLOBAL MARKET FOR OTHER BIOLOGICAL RESPONSE MODIFIERS BY
REGION, THROUGH 2016
Table 44 : GLOBAL MARKET FOR CELL DISSOCIATION REAGENTS BY REGION, THROUGH
2016
Table 45 : GLOBAL MARKET FOR OTHERS BY REGION, THROUGH 2016
Table 46 : U.S. MARKET FOR CELL CULTURE PRODUCTS, THROUGH 2016
Table 47 : U.S. MARKET FOR CELL CULTURE MEDIA, THROUGH 2016
Table 48 : U.S. MARKET FOR SERUM-REQUIRING AND SERUM-FREE MEDIA, THROUGH
2016
Table 49 : U.S. MARKET FOR POWDERED AND LIQUID MEDIA, THROUGH 2016
Table 50 : U.S. MARKET FOR CLASSICAL AND SPECIALTY MEDIA, THROUGH 2016
Table 51 : U.S. MARKET FOR BOVINE AND OTHER SERA, THROUGH 2016
Table 52 : U.S. MARKET FOR CELL CULTURE REAGENTS, THROUGH 2016
Table 53 : U.S. MARKET FOR BIOLOGICAL RESPONSE MODIFIERS, THROUGH 2016
Table 54 : U.S. MARKET SHARES OF SERUM-FREE MEDIA, 2010
Table 55 : U.S. MARKET SHARES OF SERUM-CONTAINING MEDIA, 2010
Table 56 : U.S. MARKET SHARES OF POWDERED MEDIA, 2010
Table 57 : U.S. MARKET SHARES OF LIQUID MEDIA, 2010
Table 58 : U.S. MARKET SHARES OF CLASSICAL MEDIA, 2010
Table 59 : U.S. MARKET SHARES OF SPECIALTY MEDIA, 2010
Table 60 : U.S. MARKET SHARES OF BOVINE SERA, 2010
Table 61 : U.S. MARKET SHARES OF OTHER SERA, 2010
Table 62 : U.S. MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS, 2010
Table 63 : U.S. MARKET SHARES OF CELL DISSOCIATION REAGENTS, 2010
Table 64 : U.S. MARKET SHARES OF OTHER REAGENTS, 2010
Table 65 : EUROPEAN MARKET FOR CELL CULTURE PRODUCTS, THROUGH 2016
Table 66 : EUROPEAN MARKET FOR CELL CULTURE MEDIA, THROUGH 2016
Table 67 : EUROPEAN MARKET FOR SERUM-REQUIRING AND SERUM-FREE MEDIA,
THROUGH 2016
Table 68 : EUROPEAN MARKET FOR POWDERED AND LIQUID MEDIA, THROUGH 2016
Table 69 : EUROPEAN MARKET FOR CLASSICAL AND SPECIALTY MEDIA, THROUGH 2016
Table 70 : EUROPEAN MARKET FOR BOVINE AND OTHER SERA, THROUGH 2016
Table 71 : EUROPEAN MARKET FOR CELL CULTURE REAGENTS, THROUGH 2016
Table 72 : EUROPEAN MARKET FOR BIOLOGICAL RESPONSE MODIFIERS, THROUGH 2016
Table 73 : EUROPEAN MARKET SHARES OF SERUM-FREE MEDIA BY COMPANY, 2010
Table 74 : EUROPEAN MARKET SHARES OF SERUM-FREE MEDIA BY COMPANY, 2010
Table 75 : EUROPEAN MARKET SHARES OF SERUM-CONTAINING MEDIA BY COMPANY,
2010
Table 76 : EUROPEAN MARKET SHARES OF LIQUID MEDIA BY COMPANY, 2010
Table 77 : EUROPEAN MARKET SHARES OF CLASSICAL MEDIA BY COMPANY, 2010
Table 78 : EUROPEAN MARKET SHARES OF SPECIALTY MEDIA BY COMPANY, 2010
Table 79 : EUROPEAN MARKET SHARES OF BOVINE SERA BY COMPANY, 2010
Table 80 : EUROPEAN MARKET SHARES OF OTHER SERA BY COMPANY, 2010
Table 81 : EUROPEAN MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS BY
COMPANY, 2010
Table 82 : EUROPEAN MARKET SHARES OF CELL DISSOCIATION REAGENTS BY
COMPANY, 2010
Table 83 : EUROPEAN MARKET SHARES OF OTHER REAGENTS BY COMPANY, 2010
Table 84 : ASIAN MARKET FOR CELL CULTURE PRODUCTS, THROUGH 2016
Table 85 : ASIAN MARKET FOR CELL CULTURE MEDIA, THROUGH 2016
Table 86 : ASIAN MARKET FOR SERUM-REQUIRING AND SERUM-FREE MEDIA, THROUGH
2016
Table 87 : ASIAN MARKET FOR POWDERED AND LIQUID MEDIA, THROUGH 2016
Table 88 : ASIAN MARKET FOR CLASSICAL AND SPECIALTY MEDIA, THROUGH 2016
Table 89 : ASIAN MARKET FOR BOVINE AND OTHER SERA, THROUGH 2016
Table 90 : ASIAN MARKET FOR CELL CULTURE REAGENTS, THROUGH 2016
Table 91 : ASIAN MARKET FOR BIOLOGICAL RESPONSE MODIFIERS, THROUGH 2016
Table 92 : ASIAN MARKET SHARES OF SERUM-FREE MEDIA BY COMPANY, 2010
Table 93 : ASIAN MARKET SHARES OF SERUM-CONTAINING MEDIA BY COMPANY, 2010
Table 94 : ASIAN MARKET SHARES OF POWDERED MEDIA BY COMPANY, 2010
Table 95 : ASIAN MARKET SHARES OF LIQUID MEDIA BY COMPANY, 2010
Table 96 : ASIAN MARKET SHARES OF CLASSICAL MEDIA BY COMPANY, 2010
Table 97 : ASIAN MARKET SHARES OF SPECIALTY MEDIA BY COMPANY, 2010
Table 98 : ASIAN MARKET SHARES OF BOVINE SERA BY COMPANY, 2010
Table 99 : ASIAN MARKET SHARES OF OTHER SERA BY COMPANY, 2010
Table 100 : ASIAN MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS BY
COMPANY, 2010
Table 101 : ASIAN MARKET SHARES OF CELL DISSOCIATION REAGENTS BY COMPANY,
2010
Table 102 : ASIAN MARKET SHARES OF OTHER REAGENTS BY COMPANY, 2010
Table 103 : EMERGING MARKETS FOR CELL CULTURE PRODUCTS, THROUGH 2016
Table 104 : EMERGING MARKETS FOR CELL CULTURE MEDIA, THROUGH 2016
Table 105 : EMERGING MARKETS FOR SERUM-REQUIRING AND SERUM-FREE MEDIA,
THROUGH 2016
Table 106 : EMERGING MARKETS FOR POWDERED AND LIQUID MEDIA, THROUGH 2016
Table 107 : EMERGING MARKETS FOR CLASSICAL AND SPECIALTY MEDIA, THROUGH
2016
Table 108 : EMERGING MARKETS FOR BOVINE AND OTHER SERA, THROUGH 2016
Table 109 : EMERGING MARKETS FOR CELL CULTURE REAGENTS, THROUGH 2016
Table 110 : EMERGING MARKETS FOR BIOLOGICAL RESPONSE MODIFIERS, THROUGH
2016
Table 111 : MARKET SHARES OF SERUM FREE MEDIA IN THE EMERGING MARKETS BY
COMPANY, 2010
Table 112 : MARKET SHARES OF SERUM-CONTAINING MEDIA IN THE EMERGING
MARKETS BY COMPANY, 2010
Table 113 : MARKET SHARES OF POWDERED MEDIA IN THE EMERGING MARKETS BY
COMPANY, 2010
Table 114 : MARKET SHARES OF LIQUID MEDIA IN THE EMERGING MARKETS BY
COMPANY, 2010
Table 115 : MARKET SHARES OF CLASSICAL MEDIA IN THE EMERGING MARKETS BY
COMPANY, 2010
Table 116 : MARKET SHARES OF SPECIALTY MEDIA IN THE EMERGING MARKETS BY
COMPANY, 2010
Table 117 : MARKET SHARES OF BOVINE SERA IN THE EMERGING MARKETS BY
COMPANY, 2010
Table 118 : MARKET SHARES OF OTHER SERA IN THE EMERGING MARKETS BY
COMPANY, 2010
Table 119 : MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS IN THE EMERGING
MARKETS BY COMPANY, 2010
Table 120 : MARKET SHARES OF CELL DISSOCIATION REAGENTS IN THE EMERGING
MARKETS BY COMPANY, 2010
Table 121 : MARKET SHARES OF OTHER REAGENTS IN THE EMERGING MARKETS BY
COMPANY, 2010
Table 122 : GLOBAL MEDIA, SERA AND REAGENT MARKET SHARES BY END USER, 2010
Table 123 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE RESEARCH
SEGMENT, THROUGH 2016
Table 124 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE PRODUCTION
SEGMENT, THROUGH 2016
Table 125 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE CONTRACT
SEGMENT, THROUGH 2016
Table 126 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE OTHERS
SEGMENT, THROUGH 2016
Table 127 : NUMBER OF U.S. PATENTS ISSUED BY YEAR, 2007 TO OCT. 2011
Table 128 : PATENTS BY TYPE FOR MEDIA, SERA AND REAGENTS USED IN
BIOTECHNOLOGY, 2007 - 2011
Table 129 : U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS IN
BIOTECHNOLOGY BY COMPANY, 2007 TO OCT. 2011
Table 130 : U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS USED IN
BIOTECHNOLOGY BY COUNTRY, 2007 TO OCT. 2011
Table 131 : SHARES OF U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS
USED IN BIOTECHNOLOGY BY COUNTRY, 2007 - OCT. 2011
Table 132 : U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS USED IN
BIOTECHNOLOGY BY TYPE OF END USER, 2007 TO OCT. 2011
Table 133 : R&D BUDGETS OF TOP 10 COMPANIES IN 2009 AND 2010
List of Figures
Summary Figure : GLOBAL REVENUES FROM MEDIA, SERA AND REAGENTS USED IN THE
BIOTECHNOLOGY MARKET, 2009-2016
Figure 1 : GLOBAL MARKET FOR CELL CULTURE PRODUCTS, 2009-2016
Figure 2 : GLOBAL MARKET FOR MEDIA USED IN BIOTECHNOLOGY BY REGION,
2009-2016
Figure 3 : GLOBAL BIOTECHNOLOGY MEDIA MARKET SHARES BY REGION, 2010
Figure 4 : GLOBAL MARKET FOR SERUM-FREE MEDIA BY REGION, 2009-2016
Figure 5 : GLOBAL MARKET FOR SERUM-REQUIRING MEDIA BY REGION, 2009-2016
Figure 6 : GLOBAL MARKET FOR POWDERED MEDIA, 2009-2016
Figure 7 : GLOBAL MARKET FOR LIQUID MEDIA BY REGION, 2009-2016
Figure 8 : GLOBAL MARKET FOR CLASSICAL MEDIA BY REGION, 2009 - 2016
Figure 9 : GLOBAL MARKET FOR SPECIALTY MEDIA BY REGION, 2009-2016
Figure 10 : GLOBAL MARKET FOR SERA BY REGION, 2009 - 2016
Figure 11 : GLOBAL SERA MARKET SHARES BY REGION, 2010
Figure 12 : GLOBAL MARKET FOR BOVINE SERA BY REGION, 2009 - 2016
Figure 13 : GLOBAL MARKET FOR OTHER SERA BY REGION, 2009-2016
Figure 14 : GLOBAL MARKET FOR CELL CULTURE REAGENTS BY REGION, 2009-2016
Figure 15 : GLOBAL CELL CULTURE REAGENT MARKET SHARES BY REGION, 2010
Figure 16 : GLOBAL MARKET FOR BIOLOGICAL RESPONSE MODIFIERS BY REGION,
2009-2016
Figure 17 : GLOBAL MARKET FOR GROWTH FACTORS BY REGION, 2009- 2016
Figure 18 : GLOBAL MARKET FOR CYTOKINES BY REGION, 2009-2016
Figure 19 : GLOBAL MARKET FOR OTHER BIOLOGICAL RESPONSE MODIFIERS BY
REGION, 2009-2016
Figure 20 : GLOBAL MARKET FOR CELL DISSOCIATION REAGENTS BY REGION,
2009-2016
Figure 21 : GLOBAL MARKET FOR OTHERS BY REGION, 2009-2016
Figure 22 : U.S. MARKET FOR CELL CULTURE PRODUCTS, 2009-2016
Figure 23 : U.S. MARKET FOR CELL CULTURE MEDIA, 2009-2016
Figure 24 : U.S. MARKET FOR SERUM-REQUIRING AND SERUM-FREE MEDIA, 2009-2016
Figure 25 : U.S. MARKET FOR POWDERED AND LIQUID MEDIA, 2009-2016
Figure 26 : U.S. MARKET FOR CLASSICAL AND SPECIALTY MEDIA, 2009-2016
Figure 27 : U.S. MARKET FOR BOVINE AND OTHER SERA, THROUGH 2016
Figure 28 : U.S. MARKET FOR CELL CULTURE REAGENTS, 2009-2016
Figure 29 : U.S. MARKET FOR BIOLOGICAL RESPONSE MODIFIERS, 2009-2016
Figure 30 : U.S. MARKET SHARES OF SERUM-FREE MEDIA, 2010
Figure 31 : U.S. MARKET SHARES OF SERUM-CONTAINING MEDIA, 2010
Figure 32 : U.S. MARKET SHARES OF POWDERED MEDIA, 2010
Figure 33 : U.S. MARKET SHARES OF LIQUID MEDIA, 2010
Figure 34 : U.S. MARKET SHARES OF CLASSICAL MEDIA, 2010
Figure 35 : U.S. MARKET SHARES OF SPECIALTY MEDIA, 2010
Figure 36 : U.S. MARKET SHARES OF BOVINE SERA, 2010
Figure 37 : U.S. MARKET SHARES OF OTHER SERA, 2010
Figure 38 : U.S. MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS, 2010
Figure 39 : U.S. MARKET SHARES OF CELL DISSOCIATION REAGENTS, 2010
Figure 40 : U.S. MARKET SHARES OF OTHER REAGENTS, 2010
Figure 41 : EUROPEAN MARKET FOR CELL CULTURE PRODUCTS, 2009-2016
Figure 42 : EUROPEAN MARKET FOR CELL CULTURE MEDIA, 2009-2016
Figure 43 : EUROPEAN MARKET FOR CELL CULTURE MEDIA, 2009-2016
Figure 44 : EUROPEAN MARKET FOR POWDERED AND LIQUID MEDIA, THROUGH 2016
Figure 45 : EUROPEAN MARKET FOR CLASSICAL AND SPECIALTY MEDIA, THROUGH 2016
Figure 46 : EUROPEAN MARKET FOR BOVINE AND OTHER SERA, 2009-2016
Figure 47 : EUROPEAN MARKET FOR CELL CULTURE REAGENTS, THROUGH 2016
Figure 48 : EUROPEAN MARKET FOR BIOLOGICAL RESPONSE MODIFIERS, 2009-2016
Figure 49 : EUROPEAN MARKET SHARES OF SERUM-FREE MEDIA BY COMPANY, 2010
Figure 50 : EUROPEAN MARKET SHARES OF SERUM-CONTAINING MEDIA BY COMPANY,
2010
Figure 51 : EUROPEAN MARKET SHARES OF POWDERED MEDIA BY COMPANY, 2010
Figure 52 : EUROPEAN MARKET SHARES OF LIQUID MEDIA, 2010
Figure 53 : EUROPEAN MARKET SHARES OF CLASSICAL MEDIA BY COMPANY, 2010
Figure 54 : EUROPEAN MARKET SHARES OF SPECIALTY MEDIA BY COMPANY, 2010
Figure 55 : EUROPEAN MARKET SHARES OF BOVINE SERA BY COMPANY, 2010
Figure 56 : EUROPEAN MARKET SHARES OF OTHER SERA BY COMPANY, 2010
Figure 57 : EUROPEAN MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS BY
COMPANY, 2010
Figure 58 : EUROPEAN MARKET SHARES OF CELL DISSOCIATION REAGENTS BY
COMPANY, 2010
Figure 59 : EUROPEAN MARKET SHARES OF OTHER REAGENTS BY COMPANY, 2010
Figure 60 : ASIAN MARKET FOR CELL CULTURE PRODUCTS, THROUGH 2016
Figure 61 : ASIAN MARKET FOR CELL CULTURE MEDIA, THROUGH 2016
Figure 62 : ASIAN MARKET FOR SERUM-REQUIRING AND SERUM-FREE MEDIA,
2009-2016
Figure 63 : ASIAN MARKET FOR POWDERED AND LIQUID MEDIA, THROUGH 2016
Figure 64 : ASIAN MARKET FOR CLASSICAL AND SPECIALTY MEDIA, THROUGH 2016
Figure 65 : ASIAN MARKET FOR BOVINE AND OTHER SERA, 2009-2016
Figure 66 : ASIAN MARKET FOR CELL CULTURE REAGENTS, THROUGH 2016
Figure 67 : ASIAN MARKET FOR BIOLOGICAL RESPONSE MODIFIERS, 2009-2016
Figure 68 : ASIAN MARKET SHARES OF SERUM-FREE MEDIA BY COMPANY, 2010
Figure 69 : ASIAN MARKET SHARES OF SERUM CONTAINING MEDIA BY COMPANY, 2010
Figure 70 : ASIAN MARKET SHARES OF POWDERED MEDIA BY COMPANY, 2010
Figure 71 : ASIAN MARKET SHARES OF LIQUID MEDIA BY COMPANY, 2010
Figure 72 : ASIAN MARKET SHARES OF CLASSICAL MEDIA BY COMPANY, 2010
Figure 73 : ASIAN MARKET SHARES OF SPECIALTY MEDIA BY COMPANY, 2010
Figure 74 : ASIAN MARKET SHARES OF BOVINE SERA BY COMPANY, 2010
Figure 75 : ASIAN MARKET SHARES OF OTHER SERA BY COMPANY, 2010
Figure 76 : ASIAN MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS BY
COMPANY, 2010
Figure 77 : ASIAN MARKET SHARES OF CELL DISSOCIATION REAGENTS BY COMPANY,
2010
Figure 78 : ASIAN MARKET SHARES OF OTHER REAGENTS BY COMPANY, 2010
Figure 79 : EMERGING MARKETS FOR CELL CULTURE PRODUCTS, 2009-2016
Figure 80 : EMERGING MARKETS FOR CELL CULTURE MEDIA, 2009-2016
Figure 81 : EMERGING MARKETS FOR SERUM-REQUIRING AND SERUM-FREE MEDIA,
THROUGH 2016
Figure 82 : EMERGING MARKETS FOR POWDERED AND LIQUID MEDIA, 2009-2016
Figure 83 : EMERGING MARKETS FOR CLASSICAL AND SPECIALTY MEDIA, 2009 2016
Figure 84 : EMERGING MARKETS FOR BOVINE AND OTHER SERA, 2009-2016
Figure 85 : EMERGING MARKETS FOR CELL CULTURE REAGENTS, 2009-2016
Figure 86 : EMERGING MARKETS FOR BIOLOGICAL RESPONSE MODIFIERS, 2009-2016
Figure 87 : MARKET SHARES OF SERUM FREE MEDIA IN THE EMERGING MARKETS BY
COMPANY, 2010
Figure 88 : MARKET SHARES OF SERUM CONTAINING MEDIA IN THE EMERGING
MARKETS BY COMPANY, 2010
Figure 89 : MARKET SHARES OF POWDERED MEDIA IN THE EMERGING MARKETS BY
COMPANY, 2010
Figure 90 : MARKET SHARES OF LIQUID MEDIA IN THE EMERGING MARKETS BY
COMPANY, 2010
Figure 91 : MARKET SHARES OF CLASSICAL MEDIA IN THE EMERGING MARKETS BY
COMPANY, 2010
Figure 92 : MARKET SHARES OF SPECIALTY MEDIA IN THE EMERGING MARKETS BY
COMPANY, 2010
Figure 93 : MARKET SHARES OF BOVINE SERA IN THE EMERGING MARKETS BY
COMPANY, 2010
Figure 94 : MARKET SHARES OF OTHER SERA IN THE EMERGING MARKETS BY
COMPANY, 2010
Figure 95 : MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS IN THE EMERGING
MARKETS BY COMPANY, 2010
Figure 96 : MARKET SHARES OF CELL DISSOCIATION REAGENTS IN THE EMERGING
MARKETS BY COMPANY, 2010
Figure 97 : MARKET SHARES OF OTHER REAGENTS IN THE EMERGING MARKETS BY
COMPANY, 2010
Figure 98 : GLOBAL MEDIA, SERA AND REAGENT MARKET SHARES BY END USER, 2010
Figure 99 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE RESEARCH
SEGMENT, 2009-2016
Figure 100 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE PRODUCTION
SEGMENT, 2009-2016
Figure 101 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE CONTRACT
SEGMENT, 2009-2016
Figure 102 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE OTHERS
SEGMENT, 2009-2016
Figure 103 : U.S. PATENTS ISSUED BY YEAR, 2007 TO OCT. 2011
Figure 104 : PATENTS BY TYPE FOR MEDIA, SERA AND REAGENTS USED IN
BIOTECHNOLOGY, 2007 - 2011
Global Markets for Media, Sera and Reagents in Biotechnology published by BCC Research in April 12, 2012. This report consists of 268 Pages and the price starts from US $ 5450.
The contents of this page may be different from the latest version. Please contact us for details.
Press Release
Media, Sera and Reagents in Biotechnology Jumps from $2.8 Billion in 2011 to $4.2 Billion in 2016
May 14th, 2012
Global Information Inc. would like to present a new market research report, "Global Markets for Media, Sera and Reagents in Biotechnology" by BCC Research.
Global revenues for media, sera and reagents used in biotechnology totaled nearly $2.8 billion in 2011 and are expected to reach $4.2 billion in 2016, a compound annual growth rate (CAGR) of 8.8%.
Reagents accounted for nearly $1.2 billion in revenue in 2011 and the segment is expected to reach $2 billion in 2016, a CAGR of 11.3%.
Media totaled nearly $900 million in 2011 and should experience a CAGR of 9.4% to reach $1.4 billion in 2016.
Sera, worth $678 million in 2011, should reach nearly $784 million in 2016, a CAGR of 2.9%.
Demand for cell culture products, namely media, sera and reagents, is increasing, with the increasing demand for biopharmaceuticals. Cell culture, a crucial component of the life-sciences industry, has witnessed major development during the past three decades. R&D spending, along with increasing competition, patent expiries, new technologies, and an international marketplace are moving the cell-culture process in a new direction. As cell-culture technologies evolved, a number of disciplines such as cell biology, genetic engineering, protein chemistry, genomics, and chemical engineering have been successfully incorporated into the cell-culture field.
Increased demand for stem-cell therapeutics, vaccines, recombinant therapeutics, and other biotherapeutics are the major factors driving growth within the cell-culture market. The success of monoclonal antibodies (mAbs) has increased demand from contract manufacturers and consequently the market for cell-culture products in the contract segment also has increased significantly.
This study contributes to the areas of market growth in the cell-culture industry from the point of view of manufacturers and users. Biotechnological companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutes will find this study to be of interest.
